Thomas Oxley's guest appearances

Thomas Oxley

Neurology® Podcast

Neural Implant podcast - the people behind Brain-Machine Interface revolutions

Scott Kim

Andrew Trask

Matt Johnson

Mike Wilson

Arvind Gupta

Andrew Jackson

Henry Greely

Sarah Hill

Greg Gage

Kevin Warwick

Peter Frampton

Isaac Arthur

Kara Goucher

Ginger Campbell

Cory Inman

OwlTail

Thomas Oxley is a neurosurgeon who is also the founder of Synchron which makes the Stentrode. Instead of requiring invasive brain surgery for implantable neural devices, they are able to use stents such as those used in cardiology to collect neural signals   Top 3 Takeaways:  Stentrode implantation it's one of the simplest stent procedures. Got a $40 million Series B funding round from Khosla Ventures thanks to the success of in-human studies as well as the potential to piggyback off of existing hospital technologies "We see an avenue for a range of products that do not require open brain surgery that reaches all regions of the brain, that can take information out, that can take information in that are fully implanted, that is easy to put in, and that should open up a new industry to solve problems that haven't otherwise been able to be solved."  2:00 "Do you want to describe the technology?" 5:15 "What is the level of skill required for an implant of a stent?" 6:45 "How did you come up with this technology?" 9:00 "You cold-called DARPA to get funding?" 12:15 "Our device is meant to be encapsulated and so it is a benefit for us, so how did that work?" 15:00 "And then you guys got a breakthrough status in August. Do you want to describe what this is and what that meant for you guys and how you got it?" 16:00 "I'm assuming this potentially helped with the round of funding for Silicon Valley the Khosla Ventures round that you got, do you want to talk a little bit about this?" 20:00 "I have some questions about these first patients. It was done in Australia. Is there a difference or how does that work?" 22:00 "What are the plans for the future?" 25:45 "Do you have any ideas of how to be able to [have payers cover costs]?" 27:30 "We met each other at the bioelectronic medicine forum. Is this something that you've thought about?" 28:45 "I read that you guys have 60 patents. Is that true? And why so many?"   Eddie Chang's paper?  https://www.frontiersin.org/articles/10.3389/fnhum.2021.714256/full

<a href="https://www.linkedin.com/in/tomoxl/" rel="nofollow" target="_blank">Thomas Oxley</a> is a neurosurgeon who is also the founder of Synchron which makes the <a href="https://synchron.com/team" rel="nofollow" target="_blank">Stentrode</a>. Instead of requiring invasive brain surgery for implantable neural devices, they are able to use stents such as those used in cardiology to collect neural signals Top 3 Takeaways: <ul> <li>Stentrode implantation it's one of the simplest stent procedures.</li> <li>Got a $40 million Series B funding round from Khosla Ventures thanks to the success of in-human studies as well as the potential to piggyback off of existing hospital technologies</li> <li>"We see an avenue for a range of products that do not require open brain surgery that reaches all regions of the brain, that can take information out, that can take information in that are fully implanted, that is easy to put in, and that should open up a new industry to solve problems that haven't otherwise been able to be solved."</li> </ul> 2:00 "Do you want to describe the technology?" 5:15 "What is the level of skill required for an implant of a stent?" 6:45 "How did you come up with this technology?" 9:00 "You cold-called DARPA to get funding?" 12:15 "Our device is meant to be encapsulated and so it is a benefit for us, so how did that work?" 15:00 "And then you guys got a breakthrough status in August. Do you want to describe what this is and what that meant for you guys and how you got it?" 16:00 "I'm assuming this potentially helped with the round of funding for Silicon Valley the Khosla Ventures round that you got, do you want to talk a little bit about this?" 20:00 "I have some questions about these first patients. It was done in Australia. Is there a difference or how does that work?" 22:00 "What are the plans for the future?" 25:45 "Do you have any ideas of how to be able to [have payers cover costs]?" 27:30 "We met each other at the bioelectronic medicine forum. Is this something that you've thought about?" 28:45 "I read that you guys have 60 patents. Is that true? And why so many?" Eddie Chang's paper? <a href="https://www.frontiersin.org/articles/10.3389/fnhum.2021.714256/full" rel="nofollow" target="_blank">https://www.frontiersin.org/articles/10.3389/fnhum.2021.714256/full</a>

Thomas Oxley on the best neural device implantation method with his Stentrode by Synchron

Dr. David Lapides talks with Dr. Thomas Oxley about stroke as a presenting feature of COVID-19 in the young. Read Dr. Oxley's special correspondence in NEJM: https://www.nejm.org/doi/full/10.1056/NEJMc2009787. For a clearing house of neurology related information on the coronavirus go to AAN.com/COVID19 to stay up-to-date.

Dr. David Lapides talks with Dr. Thomas Oxley about stroke as a presenting feature of COVID-19 in the young. Read Dr. Oxley's special correspondence in NEJM: <a href="https://www.nejm.org/doi/full/10.1056/NEJMc2009787" rel="nofollow" target="_blank">https://www.nejm.org/doi/full/10.1056/NEJMc2009787</a>. For a clearing house of neurology related information on the coronavirus go to <a href="http://AAN.com/COVID19" rel="nofollow" target="_blank">AAN.com/COVID19</a> to stay up-to-date.

SPECIAL REPORT: Dr. Thomas Oxley talks about stroke with COVID-19 in the young